AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
FLUTAMIDE
5 registrations across 3 African markets— 4 active
Markets with FLUTAMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Flut-250 Tablets Tablet | 🇳🇬Nigeria | Dony-Triumph and Company Nigeria Limited | active | Jun 2026 |
| FLUTAPLEX 250 mg | 🇿🇦South Africa | Teva Pharmaceuticals (Pty) Ltd | suspended | Feb 2023 |
| EULEXINE COMPRIME | 🇲🇦Morocco | — | active | — |
| FLUTAM COMPRIME | 🇲🇦Morocco | — | active | — |
| ANDRAXAN COMPRIME ENROBE | 🇲🇦Morocco | — | active | — |
FLUTAMIDE in Africa — Regulatory Overview
FLUTAMIDE is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Nigeria, South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.